Wealth Enhancement Advisory Services LLC grew its holdings in Innovator IBD 50 ETF (NYSEARCA:FFTY – Free Report) by 4.6% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 28,399 shares of the company’s stock after acquiring an additional 1,238 shares during the period. Wealth Enhancement Advisory Services LLC owned about 1.14% of Innovator IBD 50 ETF worth $927,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors have also modified their holdings of FFTY. Two Sigma Investments LP acquired a new position in shares of Innovator IBD 50 ETF in the fourth quarter worth $1,138,000. NewEdge Advisors LLC acquired a new position in shares of Innovator IBD 50 ETF in the first quarter worth $306,000. Cowa LLC grew its stake in shares of Innovator IBD 50 ETF by 27.6% in the first quarter. Cowa LLC now owns 31,602 shares of the company’s stock worth $852,000 after acquiring an additional 6,839 shares in the last quarter. Finally, Del Sette Capital Management LLC grew its stake in shares of Innovator IBD 50 ETF by 36.5% in the first quarter. Del Sette Capital Management LLC now owns 12,570 shares of the company’s stock worth $339,000 after acquiring an additional 3,364 shares in the last quarter.
Innovator IBD 50 ETF Trading Up 1.4%
Innovator IBD 50 ETF stock opened at $38.00 on Friday. The stock has a market cap of $93.10 million, a P/E ratio of 30.34 and a beta of 1.14. The company has a fifty day simple moving average of $35.37 and a 200-day simple moving average of $31.31. Innovator IBD 50 ETF has a 12-month low of $22.91 and a 12-month high of $38.66.
Innovator IBD 50 ETF Company Profile
The Innovator IBD 50 ETF (FFTY) is an exchange-traded fund that is based on the IBD 50 index. The fund tracks an index of 50 US-listed stocks with aggressive growth characteristics. Holdings are selected based on fundamental and technical rankings FFTY was launched on Apr 9, 2015 and is managed by Innovator.
Featured Stories
- Five stocks we like better than Innovator IBD 50 ETF
- How to Calculate Retirement Income: MarketBeat’s Calculator
- General Dynamics Hits New Highs: Why It Might Keep Climbing
- What Are Dividend Challengers?
- Nike’s Turnaround: If the Shoe Fits, Buy It!
- Profitably Trade Stocks at 52-Week Highs
- NVIDIA Breaks Out to New Highs: What Comes Next?
Receive News & Ratings for Innovator IBD 50 ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovator IBD 50 ETF and related companies with MarketBeat.com's FREE daily email newsletter.